Wakitani et al. ask whether culture-expanded autologous mesenchymal stem cells — delivered in a type-I collagen gel — can repair large, full-thickness articular cartilage defects. Using a rabbit knee model, they compare bone-marrow-derived versus periosteum-derived MSCs against cell-free controls over 24 weeks using histological grading and mechanical indentation testing.
In 1994, there was no proven biological method for repairing large full-thickness cartilage defects. Spontaneous healing was unreliable, and existing procedures using chondrocyte transplants or periosteal grafts had limited donor availability and inconsistent results.
This paper showed for the first time that a small aspirate of autologous bone marrow could be expanded in culture and reintroduced into a massive defect with meaningful biological repair. That proof-of-concept is why bone marrow is now a routine cell source in clinical cartilage repair strategies.
When counseling patients about cell-based cartilage repair, recognize that even successful MSC-based repair produces tissue that is mechanically inferior to native cartilage at 6 months. Postoperative protected weight-bearing and continuous passive motion are not arbitrary — they reflect the compliance gap this paper quantified.
The Wakitani grading scale introduced here remains a standard outcome measure in preclinical cartilage research. Knowing its 5 domains and 14-point maximum is directly testable on the OITE and appears in the context of evaluating experimental cartilage repair quality.
Wakitani et al. ask whether culture-expanded autologous mesenchymal stem cells — delivered in a type-I collagen gel — can repair large, full-thickness articular cartilage defects. Using a rabbit knee model, they compare bone-marrow-derived versus periosteum-derived MSCs against cell-free controls over 24 weeks using histological grading and mechanical indentation testing.
In 1994, there was no proven biological method for repairing large full-thickness cartilage defects. Spontaneous healing was unreliable, and existing procedures using chondrocyte transplants or periosteal grafts had limited donor availability and inconsistent results.
This paper showed for the first time that a small aspirate of autologous bone marrow could be expanded in culture and reintroduced into a massive defect with meaningful biological repair. That proof-of-concept is why bone marrow is now a routine cell source in clinical cartilage repair strategies.
When counseling patients about cell-based cartilage repair, recognize that even successful MSC-based repair produces tissue that is mechanically inferior to native cartilage at 6 months. Postoperative protected weight-bearing and continuous passive motion are not arbitrary — they reflect the compliance gap this paper quantified.
The Wakitani grading scale introduced here remains a standard outcome measure in preclinical cartilage research. Knowing its 5 domains and 14-point maximum is directly testable on the OITE and appears in the context of evaluating experimental cartilage repair quality.